Corcept Net Debt from 2010 to 2024

CORT Stock

USD 57.54 1.62 2.90%

Corcept Therapeutics Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt will likely drop to about -142.2 M in 2024. Net Debt is the total debt of Corcept Therapeutics Incorporated minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2003-12-31

Previous Quarter

-122.9 M

Current Value

-130.5 M

Quarterly Volatility

107.4 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Corcept Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Corcept Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 4.3 M, Selling General Administrative of 193.1 M or Research Development of 193.6 M, as well as many indicators such as Price To Sales Ratio of 6.62, Dividend Yield of 0.0 or PTB Ratio of 6.97. Corcept financial statements analysis is a perfect complement when working with Corcept Therapeutics Valuation or Volatility modules.

Check out the analysis of Corcept Therapeutics Correlation against competitors.

Latest Corcept Therapeutics' Net Debt Growth Pattern

Below is the plot of the Net Debt of Corcept Therapeutics Incorporated over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Corcept Therapeutics' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Corcept Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Corcept Net Debt Regression Statistics

	Arithmetic Mean	(160,745,161)
	Coefficient Of Variation	(97.42)
	Mean Deviation	127,998,693
	Median	(104,025,000)
	Standard Deviation	156,595,974
	Sample Variance	24522.3T
	Range	464.8M
	R-Value	(0.66)
	Mean Square Error	14822.1T
	R-Squared	0.44
	Significance	0.01
	Slope	(23,193,633)
	Total Sum of Squares	343312.2T

Corcept Net Debt History

	2024	-142.2 M
	2023	-135.4 M
	2022	-435.5 M
	2021	-335.3 M
	2020	-474.3 M
	2019	-311.9 M
	2018	-206.8 M

Other Fundumenentals of Corcept Therapeutics

Net Debt To E B I T D A

Corcept Therapeutics Net Debt component correlations

	Total Assets	Accounts Payable	Total Liab	Common Stock	Property Plant Equipment	Total Stockholder Equity	Short Term Investments	Net Debt	Retained Earnings	Total Current Assets	Current Deferred Revenue	Short Term Debt	Net Tangible Assets	Capital Surpluse	Net Receivables	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock
Total Assets		0.93	0.82	0.5	0.98	1.0	0.93	-0.76	0.9	0.99	0.86	-0.54	1.0	0.86	0.93	-0.6	0.7	0.96	0.46	0.94	0.86
Accounts Payable	0.93		0.89	0.43	0.94	0.91	0.79	-0.51	0.87	0.87	0.89	-0.55	0.93	0.75	0.94	-0.5	0.64	0.83	0.34	0.8	0.87
Total Liab	0.82	0.89		0.43	0.88	0.76	0.64	-0.34	0.8	0.76	0.77	-0.32	0.81	0.71	0.82	-0.38	0.54	0.75	0.34	0.7	0.92
Common Stock	0.5	0.43	0.43		0.44	0.48	0.47	-0.53	0.18	0.51	0.38	0.16	0.44	0.69	0.49	-0.7	0.64	0.46	0.27	0.45	0.27
Property Plant Equipment	0.98	0.94	0.88	0.44		0.97	0.9	-0.67	0.92	0.96	0.86	-0.51	0.98	0.83	0.92	-0.54	0.65	0.95	0.42	0.93	0.91
Total Stockholder Equity	1.0	0.91	0.76	0.48	0.97		0.95	-0.8	0.9	0.99	0.85	-0.57	1.0	0.85	0.92	-0.61	0.7	0.96	0.46	0.94	0.83
Short Term Investments	0.93	0.79	0.64	0.47	0.9	0.95		-0.89	0.79	0.96	0.71	-0.49	0.93	0.79	0.79	-0.59	0.63	0.95	0.28	0.98	0.7
Net Debt	-0.76	-0.51	-0.34	-0.53	-0.67	-0.8	-0.89		-0.58	-0.84	-0.47	0.42	-0.74	-0.72	-0.57	0.56	-0.51	-0.81	-0.36	-0.84	-0.44
Retained Earnings	0.9	0.87	0.8	0.18	0.92	0.9	0.79	-0.58		0.88	0.83	-0.68	0.92	0.77	0.86	-0.38	0.52	0.88	0.53	0.83	0.94
Total Current Assets	0.99	0.87	0.76	0.51	0.96	0.99	0.96	-0.84	0.88		0.81	-0.53	0.98	0.87	0.88	-0.6	0.68	0.98	0.48	0.96	0.82
Current Deferred Revenue	0.86	0.89	0.77	0.38	0.86	0.85	0.71	-0.47	0.83	0.81		-0.39	0.87	0.76	0.94	-0.66	0.78	0.75	0.45	0.71	0.81
Short Term Debt	-0.54	-0.55	-0.32	0.16	-0.51	-0.57	-0.49	0.42	-0.68	-0.53	-0.39		-0.58	-0.33	-0.44	-0.14	0.02	-0.51	-0.34	-0.48	-0.48
Net Tangible Assets	1.0	0.93	0.81	0.44	0.98	1.0	0.93	-0.74	0.92	0.98	0.87	-0.58		0.84	0.93	-0.59	0.69	0.95	0.47	0.93	0.86
Capital Surpluse	0.86	0.75	0.71	0.69	0.83	0.85	0.79	-0.72	0.77	0.87	0.76	-0.33	0.84		0.83	-0.74	0.78	0.87	0.58	0.82	0.73
Net Receivables	0.93	0.94	0.82	0.49	0.92	0.92	0.79	-0.57	0.86	0.88	0.94	-0.44	0.93	0.83		-0.69	0.79	0.82	0.47	0.78	0.85
Long Term Debt Total	-0.6	-0.5	-0.38	-0.7	-0.54	-0.61	-0.59	0.56	-0.38	-0.6	-0.66	-0.14	-0.59	-0.74	-0.69		-0.96	-0.55	-0.3	-0.54	-0.35
Short Long Term Debt	0.7	0.64	0.54	0.64	0.65	0.7	0.63	-0.51	0.52	0.68	0.78	0.02	0.69	0.78	0.79	-0.96		0.63	0.36	0.6	0.51
Net Invested Capital	0.96	0.83	0.75	0.46	0.95	0.96	0.95	-0.81	0.88	0.98	0.75	-0.51	0.95	0.87	0.82	-0.55	0.63		0.45	0.99	0.81
Long Term Investments	0.46	0.34	0.34	0.27	0.42	0.46	0.28	-0.36	0.53	0.48	0.45	-0.34	0.47	0.58	0.47	-0.3	0.36	0.45		0.31	0.5
Net Working Capital	0.94	0.8	0.7	0.45	0.93	0.94	0.98	-0.84	0.83	0.96	0.71	-0.48	0.93	0.82	0.78	-0.54	0.6	0.99	0.31		0.76
Capital Stock	0.86	0.87	0.92	0.27	0.91	0.83	0.7	-0.44	0.94	0.82	0.81	-0.48	0.86	0.73	0.85	-0.35	0.51	0.81	0.5	0.76

Click cells to compare fundamentals

About Corcept Therapeutics Financial Statements

Corcept Therapeutics shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Corcept Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Corcept Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Corcept Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	-135.4 M	-142.2 M
Net Debt To EBITDA	(1.25)	(1.19)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Corcept Stock Analysis

When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Corcept Net Debt from 2010 to 2024

Latest Corcept Therapeutics' Net Debt Growth Pattern

Corcept Net Debt Regression Statistics

Corcept Net Debt History

Other Fundumenentals of Corcept Therapeutics

Corcept Therapeutics Net Debt component correlations

About Corcept Therapeutics Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Corcept Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY